Photodynamic therapy with verteporfin vs photodynamic therapy with 5% dextrose
Adverse effects: infusion‐related back pain · people with neovascular age‐related macular degeneration
Photodynamic therapy with verteporfin leads to higher adverse effects: infusion‐related back pain compared with photodynamic therapy with 5% dextrose (high certainty).
1 finding from 1 review
- Photodynamic therapy for neovascular age‐related macular degeneration 2007 · Cochrane Headline outcomes onlyRR 9.93 [2.82, 35.02]4 studies · 1439 participantsHigh